Loading...
*  Amrinone - Wikipedia
Both inotropic and lusitropic effects are the reason why amrinone is used to treat heart failure. Amrinone decreases the ... There is a net decrease in myocardial wall tension, and O2 consumption when using amrinone. Amrinone also has beneficial ... Amrinone has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR ... Amrinone should only be diluted with normal saline or 1/2 normal saline; no dextrose solutions should be used. Furosemide ...
https://en.wikipedia.org/wiki/Amrinone
*  Intravenous Amrinone: An Advance or a Wrong Step? | Annals of Internal Medicine | American College of Physicians
Amrinone is advertised as a "major advance" in inotropic therapy because of its alleged advantages of more sustained action ... Intravenous Amrinone: An Advance or a Wrong Step?. Ann Intern Med. 1985;102:399-400. doi: 10.7326/0003-4819-102-3-399 ... Amrinone is a nonglycosidic, non-catecholamine-dependent, inotropic vasodilator agent that has recently been made available for ... Intravenous Amrinone: An Advance or a Wrong Step? JOSEPH A. FRANCIOSA, M.D. ...
http://annals.org/aim/article-abstract/699502/intravenous-amrinone-advance-wrong-step
*  Use of milrinone in cardiac surgical patients | SpringerLink
Hess W. Effects of amrinone on the right side of the heart.J Cardiothorac Vasc Anesth 1989;3(Suppl 2):38-44.Google Scholar ... Amrinone versus conventional therapy in patients awaiting cardiac transplantation.Ann Thorac Surg 1989;48:665-669.Google ... Effect of amrinone on right ventricular function: Predominance of afterload reduction.Circulation 1986;74:359-366.Google ... Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe ...
https://link.springer.com/article/10.1007/BF00877820
*  Patent US6037346 - Local administration of phosphodiesterase inhibitors for the treatment of ... - Google Patents
Various compounds are known as inhibitors of phosphodiesterases are known, including vinpocetine, milrinone, amrinone, ...
http://www.google.com.au/patents/US6037346
*  Milrinone Lactate Injection - Pharmaceutical Information, Clinical Trials, Detailed Pharmacology, Toxicology
Compared with the in vitro inotropic activity of amrinone, milrinone was approximately 30 times more potent. ... In the isolated rabbit renal artery preparation milrinone and amrinone were approximately equipotent against both potassium and ... norepinephrine-induced contractions, with nifedipine being considerably more potent than either milrinone or amrinone in this ...
http://www.imedez.com/drugs/milrinone-lactate-injection/Scientific-Information.html
*  Pharmacology definition - Phosphodiesterase Inhibitor - Medical Zone
Phosphodiesterase inhibitor such as amrinone or milrinone will inhibit and block the action of phosphodiesterase/ ...
http://www.medicalzone.net/pharmacology-definition---phosphodiesterase-inhibitor.html
*  Amrinone - DrugBank
Amrinone (or inamrinone) is a type 3 pyridine phosphodiesterase inhibitor. It is used in the treatment of congestive heart ... Amrinone. Accession Number. DB01427. Type. Small Molecule. Groups. Approved. Description. Amrinone (or inamrinone) is a type 3 ... Amrinone. ATC Codes. C01CE01 - Amrinone*C01CE - Phosphodiesterase inhibitors. *C01C - CARDIAC STIMULANTS EXCL. CARDIAC ... Amrinone lactate. I229274Y5B. 75898-90-7. DOSIONJFGDSKCQ-UHFFFAOYSA-N. Prescription Products. Name. Dosage. Strength. Route. ...
https://www.drugbank.ca/drugs/DB01427
*  Amrinone lactate - Biology-Online Dictionary
Amrinone lactate 5-Amino-(3,4'-bipyridin)-6(1H)-one;an inotropic agent with vasodilator activity, used in management of ... Retrieved from "https://www.biology-online.org/dictionary/index.php?title=Amrinone_lactate&oldid=38748" ...
https://www.biology-online.org/dictionary/Amrinone_lactate
*  Tachyphylaxis with Amrinone Therapy: Association with Sequestration and Down-Regulation of Lymphocyte Beta-Adrenergic Receptors...
Tachyphylaxis with Amrinone Therapy: Association with Sequestration and Down-Regulation of Lymphocyte Beta-Adrenergic Receptors ... Tachyphylaxis with Amrinone Therapy: Association with Sequestration and Down-Regulation of Lymphocyte Beta-Adrenergic Receptors ... Interventions: A bolus of intravenous amrinone followed by a continuous infusion at 10 µg/kg · min for 72 hours. ... Study Objective: To determine whether intravenous therapy with amrinone changes number, location or function of the β- ...
https://annals.org/aim/article-abstract/702887/tachyphylaxis-amrinone-therapy-association-sequestration-down-regulation-lymphocyte-beta-adrenergic
*  High-dose Amrinone Is Required to Accelerate Rewarming from Deliberate Mild Intraoperative Hypothermia for Neurosurgical...
AMR 15 (open circle) = a group of patients who re-ceived 15 μg · kg−1· min−1amrinone with a 1.0-mg/kg loading dose of amrinone ... AMR 15 (open circle) = a group of patients who re-ceived 15 μg · kg−1· min−1amrinone with a 1.0-mg/kg loading dose of amrinone ... AMR 15 (open circle) = a group of patients who re-ceived 15 μg · kg−1· min−1amrinone with a 1.0-mg/kg loading dose of amrinone ... AMR 15 (open circle) = a group of patients who re-ceived 15 μg · kg−1· min−1amrinone with a 1.0-mg/kg loading dose of amrinone ...
https://anesthesiology.pubs.asahq.org/article.aspx?articleid=1944010
*  Amrinone and Verapamil-propranolol Induced Cardiac Depression during Isoflurane Anesthesia in Dogs | Anesthesiology | ASA...
Amrinone and Verapamil-propranolol Induced Cardiac Depression during Isoflurane Anesthesia in Dogs. Anesthesiology 6 1987, Vol. ... Amrinone and Verapamil-propranolol Induced Cardiac Depression during Isoflurane Anesthesia in Dogs ... Amrinone and Verapamil-propranolol Induced Cardiac Depression during Isoflurane Anesthesia in Dogs ... Virve H. M. Makela, Patricia A. Kapur; Amrinone and Verapamil-propranolol Induced Cardiac Depression during Isoflurane ...
https://anesthesiology.pubs.asahq.org/article.aspx?articleid=1954101
*  The effects of amrinone on platelet count, survival and function in patients with congestive cardiac failure.
... ... The platelet count was significantly and variably reduced in all patients and the reduction was related to log plasma amrinone ... In a prospective trial, the immediate and long-term haematological effects of amrinone were studied in sixteen patients with ...
http://erepository.uonbi.ac.ke:8080/xmlui/handle/11295/28477
*  Part 6: Advanced Cardiovascular Life Support | Circulation
Amrinone and Milrinone. Amrinone and milrinone are phosphodiesterase III inhibitors that have inotropic and vasodilatory ... Amrinone is administered as a dose of 0.75 mg/kg given initially over 2 to 3 minutes, followed by an infusion of 5 to 15 μg/kg ... Amrinone has a more significant effect on preload than catecholamines, and the hemodynamic effects are similar to those of ... Like amrinone, milrinone has a relatively long plasma half-life, which makes dose titration more difficult. Milrinone may also ...
http://circ.ahajournals.org/content/102/suppl_1/I-129.full
*  February 1987 - Volume 9 - Issue 2 : Journal of Cardiovascular Pharmacology
The Cardiotonic Agent Amrinone Does Not Increase Anatomic Infarct Size. Campbell, Colin A.; Mehta, Prabodh M.; Wynne, Joshua; ...
https://journals.lww.com/cardiovascularpharm/toc/1987/02000
*  Drugs for Heart Failure Flashcards by sweet sweetmintlove | Brainscape
Inamrinone (formerly Amrinone). •Milrinone 89 •Short-term IV milrinone: not associated with increased risk of mortality; ...
https://www.brainscape.com/flashcards/drugs-for-heart-failure-1543971/packs/2969303
*  Patente US6987129 - Compounds and methods for the treatment of urogenital disorders - Google Patentes
The present invention provides methods for treating a variety of urogenital disorders, such as, for example, vaginismus, dyspareunia, vulvodynia (including vulvar vestibulitis), interstitial cystitis, nonspecific urethriris (i.e., nonspecific pain and/or burning of the urinary tract) and sexual dysfunctions, such as, for example, female sexual arousal disorders and female sexual orgasmic disorders, using a variety of compounds, including, but not limited to, NO donors, calcium channel blockers, cholinergic modulators, α-adrenergic receptor antagonists, β-adrenergic receptor agonists, phosphodiesterase inhibitors, cAMP-dependent protein kinase activators (e.g., cAMP mimetics), superoxide scavengers, potassium channel activators, estrogen-like compounds, testosterone-like compounds, benzodiazepines, adrenergic nerve inhibitors, antidiarrheal agents, HMG-CoA reductase inhibitors, smooth muscle relaxants, adenosine receptor modulators, adenylyl cyclase activators, endothelin receptor antagonists,
http://www.google.es/patents/US6987129
*  Schedule H - Wikipedia
AMRINONE LACTATE 30. ANALGIN 31. ANDROGENIC ANABOLIC, OESTROGENIC & PROGESTATIONAL SUBSTANCES 32. ANTIBIOTICS ...
https://en.wikipedia.org/wiki/Schedule_H
*  Cardiology - Drugs| Medindia
Amrinone. Antiarrhythmic Agent Dobutamine Antiarrhythmic Agent Digoxin Antiarrhythmic Agent Dopamine Antiarrhythmic Agent ...
http://www.medindia.net/drugs/speciality/cardiology.htm
*  UniProt: P01375
DR DrugBank; DB01427; Amrinone. DR DrugBank; DB05676; Apremilast. DR DrugBank; DB05066; AV411. DR DrugBank; DB08904; ...
http://www.genome.jp/dbget-bin/www_bget?uniprot:P01375
*  Nitroprusside - DrugBank
Amrinone. Amrinone may increase the hypotensive activities of Nitroprusside.. Approved. Amyl Nitrite. The risk or severity of ...
https://www.drugbank.ca/drugs/DB00325
*  Meyler's Side Effects of Drugs - Elsevier Science & Technology - Literati by Credo
This updated edition in the long standing series provides the latest information on many individual drugs, including the most complete coverage of their adverse reactions and interactions.
https://corp.credoreference.com/component/booktracker/edition/11102.html
*  Welcome to HoPaCI
2013 - Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH) Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany. Disclaimer: IBIS Databases and associated information are protected by copyright. This server and its associated data and services are for academic, non-commercial use only. The Helmholtz Zentrum München has no liability for the use of results, data or information which have been provided through this server. Neither the use for commercial purposes, nor the redistribution of IBIS database files to third parties nor the distribution of parts of files or derivative products to any third parties is permitted. Commercial users shall contact the Helmholtz Zentrum München for a separate users license.. ...
http://mips.helmholtz-muenchen.de/HoPaCI/entry/show/2905?iList=26666&iList=26709&iList=26723&term=%26quot%3BTNF%26quot%3B&refFieldSingle=Gene%2FProtein%2FComplex
*  WHOCC - DDD alterations
Amrinone. 0.15. g. P. 0.5. g. P. C01CE01. 1991 Folic acid. 0.3 8). mg. O. 0.4. mg. O. B03BB01. 2003 ...
https://www.whocc.no/atc_ddd_alterations__cumulative/ddd_alterations/?order_by=4&d=DESC